audio and conversation file with AD and non-AD progression? LLM
https://cdmrp.health.mil/pubs/press/2025/25azrppreann
| Transforming Research Award | The PI must be an independent investigator at any career level. CIT Partnership Option: an eligible PI, as above, and either- Career Initiation: an investigator three or more years from their terminal degree but no more than seven years into an independent position
OR - Career Transition: an investigator transitioning from another field to the AD/ADRD/TBI/military health fields and has only nominal, if any, publications in the AD-related field.
| - Supports high-impact research that addressed the priority area of "Reduce risk and prevent AD/ADRD."
- Projects must be responsive to a FY25 AZRP TrRA focus area:
- Risk factor knowledge
- Risk reduction solutions
- Clinical trials are not supported, but studies with prospective human subjects' enrollment may be allowed.
- Applications proposing clinical studies will require community collaboration.
- Studies leveraging existing cohorts or data sets are encouraged.
- Animal studies that are fully justified for relevance to human health are allowed.
- Community collaboration is not required for projects that focus primarily on animal studies but is encouraged.
- The CIT Option is available.
- Submission of a preproposal is required; application submission is by invitation only.
| - Maximum period of performance is 4 years
Single PI:- Maximum funding of $1.0M for total costs.
CIT Partnership Option:- Maximum funding of $1.0M for total costs.
|
No comments:
Post a Comment